Michelle Evason
BSc, DVM, DACVIM (SAIM), MRCVS
Dr. Evason serves as global director of veterinary clinical education for Antech. She has worked in veterinary general practice, academia, specialty clinical practice, and the animal health industry. Dr. Evason has published on numerous infectious diseases, antimicrobial stewardship, nutrition, spectrum of care, and veterinary and pet owner education–related topics. She enjoys ferrying her 2- and 4-legged children to various activities and fulfilling most “Canuck” stereotypes.
Read Articles Written by Michelle EvasonChristian M. Leutenegger
BSc, DrMedVet, PhD, FVH
Dr. Leutenegger graduated from the University of Zurich School of Veterinary Medicine, Switzerland, in 1992. He completed a doctoral thesis on the development of recombinant vaccines for feline immunodeficiency virus. After a postdoctoral course in medical science, he completed a PhD degree testing the first DNA vaccines in veterinary medicine. He developed a strong interest in molecular immunology and virology and founded the Real-time PCR Research and Diagnostics Core Facility at the UC Davis School of Veterinary Medicine in 1999. After 13 years at IDEXX Laboratories introducing standardized molecular diagnostics in the veterinary industry, he joined Antech Diagnostics to expand the molecular testing portfolio. He has an extensive network of collaborators and has published over 200 peer-reviewed papers and book chapters.
Read Articles Written by Christian M. Leutenegger
Reports of the tapeworm Echinococcus multilocularis are increasing in the United States and Canada. Although parasite risk appeared to be confined to focal regions of Canada, infection is now being detected in dogs, humans, and wildlife in regions of the United States. Similarly, increased fecal detection of the raccoon roundworm Baylisascaris procyonis has enabled broader description of parasite geographic range. These parasites are emerging One Health concerns (animal, human, and environment), and fecal detection in dogs and cats requires immediate education of pet owners and, in some locations, reporting to public health authorities.
Take-Home Points
- Detection of E multilocularis is increasing in domestic dogs and cats, humans, and wildlife in the United States and Canada.
- Dogs and humans infected with E multilocularis can develop alveolar echinococcosis, which is often fatal.
- Most E multilocularis infections in dogs are detected through molecular fecal examination but not conventional fecal flotation tests. Dogs may or may not have clinical signs of disease.
- Increased fecal detection of B procyonis has provided a broader description of parasite geographic range and clinical features of infection.
- B procyonis infection is typically subclinical in dogs and cats; however, severe neurologic disease has been reported in humans and dogs.
- Both E multilocularis and B procyonis are One Health concerns.
- Dogs and cats serve as sentinels of disease risk for humans.
- Fecal detection of E multilocularis or B procyonis in dogs or cats requires immediate communication with pet owners.
Gastrointestinal (GI) parasites, such as tapeworms and roundworms, are frequently detected in dogs and cats by veterinary teams in day-to-day small animal practice. However, the disease risk to dogs and cats and zoonotic risk to owners vary significantly depending on the species of tapeworm or roundworm identified. For tapeworms like Echinococcus species and for the raccoon roundworm, Baylisascaris procyonis, fecal detection in a dog or cat has significance beyond their typically subclinical effects on the pet’s health status. Detection of these parasites carries significant public health (zoonotic) concern, and prompt, clear communication of disease risk, as well as counseling owners to communicate with human healthcare providers, is necessary.
Recent veterinary, human, and wildlife research has drawn attention to the emergence and range expansion of Echinococcus multilocularis.1-13 These studies, as well as case reports on E multilocularis infections and new data on B procyonis, have One Health implications. Detection of E multilocularis through routine veterinary fecal surveillance has also raised antimicrobial use questions associated with multidrug parasite protection products, warranting consideration of antimicrobial (antiparasitic) and diagnostic stewardship.
Echinococcus multilocularis
Echinococcus species are tapeworms of human, veterinary, and environmental concern in the United States and Canada.1-13 These tapeworms have complex life cycles, with domestic dogs and wild canids (coyotes, foxes, wolves) serving as definitive hosts for E multilocularis and Echinococcus granulosus sensu lato. Cystic echinococcosis can occur in humans, cervids, and livestock after infection with E granulosus sensu lato. Humans, dogs, and rodents infected with E multilocularis are at risk of alveolar echinococcosis.
Infection and Disease
Wild and domestic dogs can become infected with E multilocularis by ingesting a rodent containing a metacestode (larval stage).1-7 Dogs can also infect themselves through the oral route, typically through grooming. Development into the adult stage of the tapeworm occurs within the small intestine, and eggs are shed in the feces.1-6 These eggs are immediately infective and environmentally resistant. Recent studies have reported GI signs (diarrhea) in dogs with enteric E multilocularis; however, infections are thought to be typically subclinical in dogs.1,2,7 A recent report of PCR detection of enteric E multilocularis in a cat described GI signs (diarrhea) and resolution of E multilocularis detection with praziquantel treatment.13
Dogs—and humans—can also act as “dead-end” hosts for E multilocularis after consumption of eggs from contaminated water or food or the environment. In these cases, alveolar echinococcosis, characterized by tumor-like lesions (alveolar hydatid cysts), can develop. Alveolar echinococcosis is typically diagnosed when abdominal imaging shows these cysts within the liver, although they can form in other body locations as well.1-9 Unfortunately, alveolar echinococcosis is often fatal in both dogs and humans if undiagnosed.1-9
While detection of E multilocularis in dogs and humans remains rare, reports are increasing, particularly in regions such as Alberta, Canada, where a relatively high prevalence has been detected in wild dogs.1,2,5,11 One U.S. study in coyotes identified E multilocularis in new areas, including Illinois, Indiana, Kansas, and Missouri.12 Additionally, this study reported detection as ranging between 16% and 47%, indicating the potential for regional “spillover” into pet dogs, cats, and humans.12 Another recent publication reported fecal quantitative PCR (qPCR) results, management, preventive care status, and outcome in 26 pet dogs from Canada and the United States.1 In this research, E multilocularis was detected in dogs from novel regions of the United States, including Colorado, Idaho, Illinois, Kansas, Montana, Nevada, Oregon, Washington, and Wyoming.1
Zoonotic Risk
Zoonotic infection with E multilocularis arises from human consumption of eggs shed in dog feces.1-9 Routine fecal screening in dogs, and potentially in cats, as advised by parasite guidelines from the CAPC and Canadian Parasitology Expert Panel (CPEP), can inform the risk of human E multilocularis infection in known endemic regions and alert to emerging risks.14,15
In veterinary medicine, fecal centrifugal flotation combined with microscopy is often used for fecal screening. However, this test, even when performed by reference laboratories, has low sensitivity for Echinococcus species. Further, eggs of Taenia species cannot be microscopically differentiated from those of Echinococcus species.1-9 The CAPC and CPEP advise use of fecal qPCR testing for dogs living in (or traveling to) E multilocularis endemic regions, for dogs in regions considered high risk, and whenever taeniid eggs are found in dog feces to alert to both dog and human risk.14,15
In some regions, human health guidelines advise a risk assessment be performed for humans in contact with a dog shedding E multilocularis eggs.16
Few reports of E multilocularis detection in cats are available, aside from morphologic descriptions of worms observed in necropsy findings in Saskatchewan and North Dakota from the 1970s.17 E multilocularis prevalence in cats in the United States and Canada is currently unknown. In endemic regions in Europe, where prevalence rates in foxes are 35% (France), 48.2% (Poland), and 53% (Switzerland), detection of E multilocularis in cats has been between 7% and 9.3%, 6%, and < 1%, respectively.18-20 A recently published report of E multilocularis detection in a cat through fecal qPCR testing provides much-needed outcome information on resolution of detection after praziquantel treatment and serves to highlight the infection risk for cats with outdoor access or hunting behaviors as well as a reminder of the zoonotic risk potential in felines.13
Public Health, Antimicrobial Use, and Stewardship Considerations
If a dog or cat tests positive for E multilocularis, the veterinary team should immediately inform the owners of zoonotic risk potential and advise them to promptly connect with their healthcare provider to decide on next diagnostic or medical decisions. In some U.S. states and Canadian provinces, detection is also reportable to public health authorities. Other dogs, and potentially cats, in the household of an infected animal should also be tested and treated, along with the affected pet, with praziquantel.1,14-16
The commercial availability of multidrug parasite preventives has raised questions surrounding antimicrobial (antiparasitic) and diagnostic stewardship. While tapeworm resistance is an evolving concern for Dipylidium caninum, it is not known if this will be a concern for Echinococcus species. As such, recommendations surrounding screening and prevention (i.e., test and then treat, treat every 3 months, or treat monthly) are not yet clear, and further research is indicated.
Baylisascaris procyonis
B procyonis is highly prevalent in raccoons, and humans and dogs may become infected after ingestion of eggs. In the United States and Canada, the parasite is typically found in dogs incidentally during fecal screening and may reflect either transient egg shedding (due to coprophagy) or true enteric infection.20,21 GI infection with B procyonis is not thought to cause clinical disease in dogs or cats. However, rare case reports of neural larva migrans have been described in infected dogs, and neurologic disease, in some cases fatal, has been reported in humans.22,23
Veterinary clinics that use fecal flotation and microscopy as the sole method of screening in dogs and cats are at risk of misidentifying B procyonis as Toxocara canis or Toxocara cati. These two roundworms can be differentiated through fecal qPCR testing or by very careful microscopic review (e.g., slight size and color difference in eggs and outer shell).15,20,21,24
Zoonotic Risk
High human B procyonis seroprevalence was described in a study from California, indicating exposure risk for people and dogs from common environmental sources (e.g., raccoon latrines).23 Recent fecal qPCR surveillance in dogs and cats has detected B procyonis in multiple regions of the United States and Canada.21
B procyonis eggs observed on microscopy in dogs or cats living in or travelling from endemic regions must be promptly differentiated from T canis and T cati eggs. Additionally, animals infected with B procyonis should be immediately treated with routine dewormers due to zoonotic risk, and testing other household pets should be considered.15,20,23,24
As with E multilocularis, fecal detection of raccoon roundworm in a dog or cat should be immediately communicated to the owners so they may promptly contact their healthcare provider. Owners should be made aware of the risk for zoonotic infectious disease and counseled to contact their healthcare provider for potential consideration of prophylactic therapy.15,20-25 They should also be educated about how to reduce exposure to raccoons (e.g., removal of raccoon latrines) and to promptly dispose of dog and cat feces.
Summary
Routine veterinary fecal screening in dogs and cats will be a critical component of ongoing One Health surveillance for emergence of E multilocularis, as well as for raising awareness of dog and human disease risk associated with both B procyonis and Echinococcus species. Further interdisciplinary efforts and collaboration between wildlife, human, and veterinary researchers is indicated to assist in provision of information that benefits pet and human health.
References
- Evason MD, Peregrine AS, Jenkins EJ, et al. Emerging Echinococcus tapeworms: fecal PCR detection of Echinococcus multilocularis in 26 dogs from the United States and Canada (2022-2024). JAVMA. 2024;263(2):1-5. doi:10.2460/javma.24.07.0471
- Kolapo TU, Hay A, Gesy KM, et al. Canine alveolar echinococcosis: an emerging and costly introduced problem in North America. Transbound Emerg Dis. 2023;2023:5224160. doi:10.1155/2023/5224160
- Williams LBA, Walzthoni N. Diagnosis, treatment, and outcome of four dogs with alveolar echinococcosis in the northwestern United States. JAVMA. 2023;261(7):1-6. doi:10.2460/javma.22.12.0540
- Kotwa JD, Greer T, Jardine CM, et al. Evaluation of the prevalence of Echinococcus multilocularis in dogs that visit off-leash dog parks in southern Ontario, Canada. Zoonoses Public Health. 2021;68(5):533-537. doi:10.1111/zph.12792
- Toews E, Musiani M, Smith A, Checkley S, Visscher D, Massolo A. Risk factors for Echinococcus multilocularis intestinal infections in owned domestic dogs in a North American metropolis (Calgary, Alberta). Sci Rep. 2024;14(1):5066. doi:10.1038/s41598-024-55515-6
- Peregrine AS, Jenkins EJ, Barnes B, et al. Alveolar hydatid disease (Echinococcus multilocularis) in the liver of a Canadian dog in British Columbia, a newly endemic region. Can Vet J. 2012;53(8):870-874.
- Evason MD, Jenkins EJ, Kolapo TU, Mitchell KD, Leutenegger CM, Peregrine AS. Novel molecular diagnostic (PCR) diagnosis and outcome of intestinal Echinococcus multilocularis in a dog from western Canada. JAVMA. 2023;261(9):1-3. doi:10.2460/javma.23.03.0179
- Joyce J, He XO, Rozovsky K, Stefanovici C, Fanella S. Disseminated Echinococcus multilocularis infection without liver involvement in child, Canada, 2018. Emerg Infect Dis. 2020;26(8):1856-1859. doi:10.3201/eid2608.191644
- Zhang N, Vuppala NK, Boney CP, et al. Primary pulmonary echinococcosis in the United States: a case report and review of the literature. Cureus. 2024;16(3):e55591. doi:10.7759/cureus.55591
- Polish LB, O’Connell EM, Barth TFE, et al. European haplotype of Echinococcus multilocularis in the United States. N Engl J Med. 2022;387(20):1902-1904. doi:10.1056/NEJMc2210000
- Catalano S, Lejeune M, Liccoli S, et al. Echinococcus multilocularis in urban coyotes, Alberta, Canada. Emerg Infect Dis. 2012;18(10):1625-1628. doi:10.3201/eid.1810.120119
- Miller K, Raya B, Kollasch T, Ryan W, Herrin B. Detection of Echinococcus spp. in coyotes in the Midwestern United States. Presented at: American Association of Veterinary Parasitologists 68th Annual Meeting; June 10-13, 2023; Lexington, Kentucky.
- Langs Rund L, Evason MD, Weese JS, Leutenegger CM. Echinococcus multilocularis in a cat: novel report of molecular detection (quantitative polymerase chain reaction) and management in a domestic cat from Canada. Am J Vet Res. 2025;86(7):ajvr.25.02.0072. doi:10.2460/ajvr.25.02.0072
- Echinococcus spp. Companion Animal Parasite Council. Updated February 7, 2025. Accessed May 2024. https://capcvet.org/guidelines/echinococcus-spp
- Conboy G, Prada CF, Gilleard J, et al. Canadian Parasitology Expert Panel guidelines for the management of parasites in dogs and cats. Accessed May 2024. https://research-groups.usask.ca/cpep/index.php
- Ontario Ministry of Health. Management of Echinococcus multilocularis infections in animals guideline, 2025. Accessed June 10, 2025. https://www.ontario.ca/files/2024-12/moh-guidelines-management-of-echinococcus-multilocularis-infections-animals-en-2025-01-02.pdf
- Massolo A, Liccoli S, Budke C, Klein C. Echinococcus multilocularis in North America: the great unknown. Parasite. 2014;21:73. doi:10.1051/parasite/2014069
- Karamon J, Sroka J, Dabrowska J, et al. First report of Echinococcus multilocularis in cats in Poland: a monitoring study in cats and dogs from a rural area and animal shelter in a highly endemic region. Parasit Vectors. 2019;12(1):313. doi:10.1186/s13071-019-3573-x
- Furtado Jost R, Müller N, Marreros N, et al. What is the role of Swiss domestic cats in environmental contamination with Echinococcus multilocularis eggs? Parasit Vectors. 2023;16(1):353. doi:10.1186/s13071-023-05983-y
- French SK, Pearl DL, Peregrine AS, Jardine CM. Baylisascaris procyonis infection in raccoons: a review of demographic and environmental factors influencing parasite carriage. Vet Parasitol Reg Stud Reports. 2019;16:100275. doi:10.1016/j.vprsr.2019.100275
- Teng E, Castro JP, Evason M, et al. Baylisascaris procyonis (raccoon roundworm) detection in dogs and cats from the United States and Canada. Poster presented at: ACVIM Forum 2025; June 19-21, 2025: Louisville, Kentucky.
- Lipton BA, Oltean HN, Capron RB, et al. Baylisascaris procyonis roundworm infection in child with autism spectrum disorder, Washington, USA, 2022. Emerg Infect Dis. 2023;29(6):1232-1235. doi:10.3201/eid2906.230290
- Weinstein SB, Lake CM, Chastain HM, et al. Seroprevalence of Baylisascaris procyonis infection among humans, Santa Barbara County, California, USA, 2014-2016. Emerg Infect Dis. 2017;23(8):1397-1399. doi:10.3201/eid2308.170222
- Baylisascaris procyonis. Companion Animal Parasite Council. Updated March 27, 2023. Accessed May 2024. https://capcvet.org/guidelines/baylisascaris-procyonis
- Davidson RK, Øines Ø, Hamnes IS, Schulze JE. Illegal wildlife imports more than just animals—Baylisascaris procyonis in raccoons (Procyon lotor) in Norway. J Wildl Dis. 2013;49(4):986-990. doi:10.7589/2012-06-154
